Strategic capital doubles down on efficacy skincare: The structural opportunity behind the numbers

Strategic capital doubles down on efficacy skincare has been gaining momentum. Data shows that in Q4, online channel share reached 15.8%, and industry attention is clearly rising. This piece breaks down the structural opportunity behind the numbers using public information and platform data.

Supply-side changes are equally visible. Proya Lab’s layout in Guangzhou, together with pricing from new entrants, is driving this round of adjustment — and concentration is moving with it.

On the data side, online channel share reached 15.8%, with month-on-month improvement through Q4. This suggests the structural opportunity behind the numbers is a structural trend rather than short-term noise.

For practitioners, three directions follow: differentiate product and content back to R&D and supply chain; build localisation capability for markets such as Guangzhou; and treat compliance and data capability as the new moat.

Bottom line: strategic capital doubles down on efficacy skincare is moving from concept to execution — the structural opportunity behind the numbers. Brands should review strategy before Q4 and prioritise channels and segments with higher certainty.

Related